Pharming Group company profile

Company profile

Pharming Group has 407 employees and is headquartered in Leiden, Netherlands.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Company facts

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

Headquarters

Darwinweg 24, 2333 CR, Leiden

Employees

407

Listing

PHARM · Euronext Amsterdam

Currency

EUR

ISIN

NL0010391025

Website

pharming.com